BILL · 2019–20 SESSION

HB 1525: Digoxin & KCl/med procedures

Addressing the use of potassium chloride or digoxin in medical procedures.

Summary

  • Requires a hospital or health care facility, in which an abortion is performed, to report to the department of health whether an intrafetal injection was used in an attempt to induce fetal demise, such as intrafetal potassium chloride or digoxin.

From the Bill Digest (HB 1525), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 23, 2019
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Luanne Van Werven (R-42)
Introduced
January 23, 2019 in the House
Last action
January 13, 2020

AN ACT Relating to the use of potassium chloride or digoxin in medical procedures;

Sponsors

Prime sponsor: Luanne Van Werven (R-42)

3 co-sponsors (0 Democrats, 3 Republicans)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. First reading, referred to Health Care & Wellness.

HB 1525 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page